What is the main business of JWB?

The main business activity of JWB focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 7, 2004.

Where is the headquarters located?

The headquarters is located at: ul. Kinga C. Gillette 11, 94-406 Łódź.

Who is on the management board?

The management board includes: Bożena Helena Szymańska (President of the Management Board) and Katarzyna Nockowska Stańczak (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 11,369,500 (approx. $3.1 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $27,025,790 in 2024, which is an increase of 11.3% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $910,289, meaning the company increased its profit by 28.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $20,590,766 in 2024, representing 80% of all operating expenses.

JWBsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-07-07

Share capital

11 369 500,00 PLN

Registered address

ul. Kinga C. Gillette 11, 94-406 Łódź, Poland

Electronic delivery address

AE:PL-83816-78996-UVSTB-21

Financials

Revenue history (in m)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 30.91mMedianUSD 1.76mAverageUSD 4.96m

Net profit

This companyUSD 872.99kMedianUSD 17.49kAverageUSD 77.31k

Operating costs

This companyUSD 29.66mMedianUSD 1.72mAverageUSD 4.80m

Assets

This companyUSD 10.32mMedianUSD 495.60kAverageUSD 1.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2004-07-05. Active

ING Bank Śląski
03 1050 0086 1000 0090 3242 1027
Bank Pekao SA
39 1240 5585 1111 0000 4884 7050
Bank Pekao SA
69 1240 6292 1111 0010 3989 1252

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Apr 8, 2014	Commercial Companies Code notice
Nov 8, 2013	Merger plan

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Aleksandra Olszacka — Vice President of the Management Board

Bożena Helena Szymańska — President of the Management Board

Katarzyna Nockowska Stańczak — Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, two members of the management board acting jointly or one member of the management board acting together with a commercial proxy are authorized to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
DOZ S.A.	5,457	$737,034.04	23.9984%
Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm - Kraków S.A.	17,278	$2,333,603.46	75.984%
Others	4	$540.25	0.0176%

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki
Jacek Romuald Szwajcowski (62)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki

Competitors

Name	Revenue	Website
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
Dolnośląska Grupa AptecznaS.A.	$30,168,188.68	dgasa.pl
Farmacja SpołecznaS.A.	$28,931,457.55	farmacjaspoleczna.ap.info.pl
Cefarm RzeszówS.A.	$28,356,418.72	cefarmrzeszow.pl
Management CompanyS.A.	$18,905,980.22	managementcompany.pl
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.	$16,601,428.28	apimex.pl
APIS Farmacjasp. z o.o.	$14,614,704.02	apisapteka.pl
Farmjugsp. z o.o.	$14,506,326.49	farmjug.pl
Pikadasp. z o.o.	$1,903,088.18	apteka-propharma.pl
Awicennasp. j.	—	a-medyczny.pl

Change history

Date	Event
2024-08-21	Address change (Grunwaldzka 64, 81-771, Sopot → Ul. Kinga C. Gillette 11, 94-406, Łódź)
2018-02-15	Share capital change (11,367,500.00 PLN → 11,369,500.00 PLN)
2015-08-04	PKD change (Removed: 10.86.Z, 10.89.Z, 21.10.Z, 49.41.Z, 63.11.Z, 63.12.Z, 64.20.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B)
2014-03-31	Share capital change (5,060,000.00 PLN → 11,367,500.00 PLN)
2010-02-23	PKD change (Removed: 51, 52, 70, 73, 74.13, 74.14, 74.2, 74.3, 74.4, 74.5, 74.8; Added: 10.86.Z, 10.89.Z, 21.10.Z, 21.20.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 49.41.Z, 52.10.B, 63.11.Z, 63.12.Z, 64.20.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B, 86.90.E)

FAQ

Last updated: 2026-07-10